HLA-DMA and neoplasm: The absence of HLA-DM in MHC-II-positive cells might lead to the presentation of non-immunogenic CLIP instead of potentially immunogenic peptides by tumor cells, which could explain their poor immunostimulatory capacity in the allogenic T-cell assays.